Levetiracetam

Historical note and nomenclature
Article section 1 of 12.  Next

By K K Jain MD

Levetiracetam is a pyrrolidone derivative and not related to any of the antiepileptic drugs currently in use. It has been approved by the Food and Drug Administration in the United States, and also in the European Union and various other countries. Although levetiracetam is more expensive than traditional antiepileptic drugs, its cost is comparable to that of newer antiepileptic drugs.

In This Article

Historical note and nomenclature
Pharmacology
Clinical trials
Indications
Contraindications
Goals and duration of treatment
Dosing
Special considerations
Interactions
Adverse effects
References cited
Contributors